The market has priced in a bleak scenario for Nu Skin (NYSE:NUS), providing an opportunity to purchase the stock at an attractive value. Nu Skin's stock fell 44.43% from $132.89 to $73.84 between the start of China's probe in January 2014 and when it concluded four months later in May. The probe resulted in a small fine totaling $781,000 and no other serious sanctions against Nu Skin. In order to ensure compliance, management voluntarily suspended new recruits and sales events in China, both of which has resumed in August of 2014. Read more